Related Experiment Video
Updated: Apr 8, 2026

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
Vancomycin minimum inhibitory concentrations and lethality in Staphylococcus aureus bacteremia
Felipe Sulla1, Daniel T Bussius1, Felipe Acquesta1
1Division of Microbiology, Department of Pathology, Santa Casa School of Medicine, São Paulo, Brazil.
Background:
After the dissemination of penicillin and oxacillin resistance in Staphylococcus aureus, vancomycin-intermediate and vancomycin resistant isolates have been reported. Even between isolates with minimum inhibitory concentrations (MICs) within the susceptible range, some authors have demonstrated that higher MICs correlate with higher lethality.
Methods:
To test this hypothesis in our setting, we compared vancomycin MICs evaluated by two methods and clinical outcomes in hospitalized patients with S. aureus bacteremia.
Results:
We compared lethality in patients infected with isolates that had MICs under or over 2 mg/L. Among patients infected with isolates that had microdilution MICs <2 mg/L, the lethality was 25%; among patients infected with strains that had microdilution MICs ≥2 mg/L, 33% died. Among patients infected with isolates that had Etest MICs <2 mg/L, 23% died; in comparison, patients infected with strains that had Etest MICs ≥2 mg/L had a lethality of 44%.
Conclusion:
Our results showed a slight tendency of higher lethality when higher MICs were present. However, this difference did not reach statistical significance, possibly due to the relatively small number of patients included in the study. Future prospective studies are needed to further evaluate this correlation and to help clinicians guide antimicrobial therapy.
Insights
Higher vancomycin minimum inhibitory concentrations (MICs) in Staphylococcus aureus bacteremia showed a trend toward increased patient lethality, though not statistically significant. Further research is needed to confirm this link and guide treatment.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Pharmacology
Background:
- Increasing antibiotic resistance in Staphylococcus aureus, including penicillin and oxacillin resistance.
- Emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates.
- Previous studies suggest a correlation between higher vancomycin minimum inhibitory concentrations (MICs) and increased lethality, even within the susceptible range.
Purpose of the Study:
- To investigate the association between vancomycin MICs and clinical outcomes in patients with Staphylococcus aureus bacteremia.
- To compare vancomycin MICs determined by two different methods (microdilution and Etest) and their correlation with patient lethality.
Main Methods:
- Retrospective analysis of hospitalized patients with Staphylococcus aureus bacteremia.
- Comparison of vancomycin MICs using microdilution and Etest methods.
- Correlation of MIC values (categorized as <2 mg/L and ≥2 mg/L) with patient lethality.
Main Results:
- Lethality was 25% for isolates with microdilution MICs <2 mg/L and 33% for MICs ≥2 mg/L.
- Lethality was 23% for isolates with Etest MICs <2 mg/L and 44% for MICs ≥2 mg/L.
- A slight trend of increased lethality with higher MICs was observed, but did not reach statistical significance.
Conclusions:
- The study indicated a potential trend between higher vancomycin MICs and increased lethality in Staphylococcus aureus bacteremia.
- The observed difference lacked statistical significance, likely due to a small patient cohort.
- Prospective studies are recommended to further elucidate this correlation and inform clinical antimicrobial therapy decisions.
More Related Videos
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
11:28A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Estimation of k and VD of Aminoglycosides
Mechanism of Antibiotic Resistance in MRSA
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pharmacodynamic Models: Overview
Inhibitors of Bacterial Protein Synthesis